Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies
Author(s) -
Elvira L. Vos,
Erin SaloMullen,
Laura H. Tang,
Mark Schattner,
Sam S. Yoon,
Hans Gerdes,
Arnold J. Markowitz,
Diana Mandelker,
Yelena Y. Janjigian,
Kenneth Offitt,
Daniel G. Coit,
Zsofia K. Stadler,
Vivian E. Strong
Publication year - 2020
Publication title -
jama surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.757
H-Index - 176
eISSN - 2168-6262
pISSN - 2168-6254
DOI - 10.1001/jamasurg.2020.3356
Subject(s) - medicine , esophagogastroduodenoscopy , gastrectomy , interquartile range , cancer , signet ring cell carcinoma , breast cancer , cdh1 , surgery , surgical oncology , gastroenterology , general surgery , oncology , endoscopy , adenocarcinoma , cadherin , genetics , biology , cell
CDH1 variants are increasingly identified on commercially available multigene panel tests, calling for data to inform counseling of individuals without a family history of gastric cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom